4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-15-040442
Options or other derivatives
- CEO & Executive Chariman acquired 163,437 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| MENDLEIN JOHN CEO & Executive Chariman | 2015-05-06 | Grant or award · Stock Option (right to buy) | +163,437 | 163,437 | D | ||
Loading xslF345X03/doc4.xml…